Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome - A randomised controlled trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 25, Issue 3, 2015, Pages 287-294

  Witham, M D ^a   Adams, F ^a   McSwiggan, S ^a   Kennedy, G ^a   Kabir, G ^a   Belch, J J F ^a   Khan, F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Arterial stiffness; Chronic fatigue; Randomised controlled trial; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CHOLESTEROL; COLECALCIFEROL; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTHELIAL FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PIPER FATIGUE SCALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; BLOOD; BRACHIAL ARTERY; CANADA; CARDIOVASCULAR FUNCTION; COMPLICATION; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; FATIGUE SYNDROME, CHRONIC; METABOLISM; PULSE WAVE; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

ADULT; BIOMARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CANADA; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CHOLECALCIFEROL; CHOLESTEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULSE WAVE ANALYSIS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VITAMIN D DEFICIENCY;

EID: 84933505876     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.10.007     Document Type: Article

References (30)

1. Spence V.A., Kennedy G., Belch J.J., Hill A., Khan F. Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clin Sci (Lond) 2008 Apr, 114(8):561-566.
2. Newton D.J., Kennedy G., Chan K.K., Lang C.C., Belch J.J., Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol 2012, 154(3):335-336.
3. Hollingsworth K.G., Hodgson T., Macgowan G.A., Blamire A.M., Newton J.L. Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging. J Intern Med 2012 Mar, 271(3):264-270.
4. Beveridge L.A., Witham M.D. Vitamin D and the cardiovascular system. Osteoporos Int 2013, 24(8):2167-2180.
5. Elamin M.B., Abu Elnour N.O., Elamin K.B., Fatourechi M.M., Alkatib A.A., Almandoz J.P., et al. Vitamin d and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96(7):1931-1942.
6. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152(5):307-314.
7. Berkovitz S., Ambler G., Jenkins M., Thurgood S. Serum 25-hydroxy vitamin D levels in chronic fatigue syndrome: a retrospective survey. Int J Vitam Nutr Res 2009, 79(4):250-254.
8. Witham M.D., Kennedy G.Y., Belch J.J.F., Hill A., Khan F. Association between vitamin D status and markers of vascular health in patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Int J Cardiol 2014, 174(1):139-140.
9. Reid D., Toole B.J., Knox S., Talwar D., Harten J., O'Reilly D.S., et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr 2011, 93(5):1006-1011.
10. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121(12):953-959.
11. Carruthers B.M., Jain A.K., De Meirleir K.L. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Sy 2003, 11(1):117.
12. Ben-Shlomo Y., Spears M., Boustred C., May M., Anderson S.G., Benjamin E.J., et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014, 63(7):636-646.
13. Al Mheid I., Patel R., Murrow J., Morris A., Rahman A., Fike L., et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011, 58(2):186-192.
14. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605.
15. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39(2):257-265.
16. Piper B. Measuring fatigue. Instruments for clinical health care research 1997, 482-496. Jones and Barlett, London. M. Stromborg, J. Olsen (Eds.).
17. Rodriguez T. The challenge of evaluating fatigue. J Am Acad Nurse Pract 2000, 12(8):329-338.
18. Favrat B., Balck K., Breymann C., Hedenus M., Keller T., Mezzacasa A., et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women - PREFER a randomized, placebo-controlled study. PLoS One 2014, 9(4):e94217.
19. Mihrshahi R., Beirman R. Aetiology and pathogenesis of chronic fatigue syndrome: a review. N Z Med J 2005, 118(1227):U1780.
20. Morris G., Berk M., Galecki P., Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Mol Neurobiol 2014, 49(2):741-756.
21. Pedersen B.K. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 2006, 42:105-117.
22. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84(1):18-28.
23. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325.
24. Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53(10):2112-2119.
25. Witham M.D., Dove F.J., Sugden J.A., Doney A.S., Struthers A.D. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012, 22(10):864-870.
26. Taylor R.R., Jason L.A., Torres A. Fatigue rating scales: an empirical comparison. Psychol Med 2000, 30(4):849-856.
27. Jason L.A., Evans M., Brown M., Porter N., Brown A., Hunnell J., et al. Fatigue scales and chronic fatigue syndrome: issues of sensitivity and specificity. Disabil Stud Q 2011, 31(1).
28. Waterhouse J.C., Perez T.H., Albert P.J. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann N Y Acad Sci 2009, 1173:757-765.
29. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., et al. Vitamin D, parathyroid hormone and cardiovascular events among older adults. J Am Coll Cardiol 2011, 58(14):1433-1441.
30. Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003, 24(22):2054-2060.